Deepak Fertilisers & Petrochemicals Corp LtdNSE: DEEPAKFERT
Open the Deepak Fertilisers & Petrochemicals Corp Ltd page
Follow Deepak Fertilisers & Petrochemicals Corp LtdFree account. Get a note when Deepak Fertilisers & Petrochemicals Corp Ltd files.
Q2 FY27 earnings call · November 16, 2026

Deepak Fertilisers Q2 FY27 Earnings Call: EBITDA Jumps 62% on Record Quarter, Nitric Acid Capacity to More Than Double (DEEPAKFERT)

Cofacto ResearchPublished November 16, 20268 min read
Quick summary

Deepak Fertilisers & Petrochemicals Corp Ltd held its Q2 FY27 earnings call on November 13, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Best-Ever Quarter: Record EBITDA and PAT on Margin Expansion

  • Q2 FY 2026-2027 revenue of Rs.3,334 crore, up 11% YoY — driven by better realization and healthy volumes; EBITDA of Rs.750 crore rose 62% YoY with margin at 22.5% versus 15.5% in Q2 FY 2025-2026.
  • PAT of Rs.394 crore, up 84% YoY — Chairman S. C. Mehta called Q2 the company's best-ever EBITDA and PAT quarter, with EBITDA margins the highest of the last five years.
  • Record H1 FY 2026-2027 — revenue up 16% YoY to Rs.6,590 crore, operating EBITDA up 63% to Rs.1,595 crore, and PAT up 93% to Rs.884 crore; Mehta said H1 was "almost touching" full-year profits for FY 2025-2026.
  • Margin drivers — CFO Subhash Anand attributed expansion to the long-term LNG sourcing arrangement, in-house ammonia integration, better product mix, and stronger downstream value-added product contribution.
  • Net debt of Rs.4,743 crore — net debt to EBITDA at about 1.5x as of Q2 FY 2026-2027; H1 capex was approximately Rs.774 crore, and Mehta said the company is approaching the end of its capex cycle.
  • No material inventory gains in the P&L — the CFO said gas, ammonia, and finished goods are procured just in time; the inventory increase versus March-end sits entirely in crop nutrition, built for Rabi stock after a soft monsoon hit Kharif demand, with liquidation expected to begin in the Rabi season FY 2026-2027.

Mining Chemicals, Industrial Chemicals, Crop Nutrition

  • Mining chemicals volumes moderated in Q2 FY 2026-2027 — monsoon-related disruptions weighed on volume, while improved realization supported healthy revenue growth; B2C contributed about 16% of segment revenue versus 14% a year earlier.
  • Nitric acid volume grew 14% YoY in Q2 FY 2026-2027 — though pricing remained soft on higher availability; IPA volume was 17 KT with sequential improvement despite a temporary RGP supply constraint, and realizations stayed strong on pharma-grade sales mix.
  • Crop nutrition faced a challenging quarter — the CFO cited uneven rainfall, phosphoric acid availability, and elevated channel inventory during kharif; improved realization and subsidy support lifted profitability sequentially, with crop tech and specialty fertilizers at about 28% of segment revenue.
  • Trading revenue nearly doubled sequentially in chemicals — the CFO clarified trading is mainly in the C&B (fertilizer) business; in chemicals it is limited to ammonia (the company is the largest ammonia producer), with no nitric acid or TAN trading, and he described the chemical businesses as "purely 100% in-house businesses, majority of the businesses."
  • Fertilizer margins were thin in Q1 FY 2026-2027 — the CFO said the business was not substantially profitable and expects normal fertilizer-business margins in Q3 and Q4 FY 2026-2027, agreeing that 5-7% would be broadly in that range.

Dahej and Gopalpur Near Completion; Structural Volume Step-Up

  • Dahej nitric acid and Gopalpur TAN projects are about 98% complete — both are expected to commence operations in Q4 FY27 and remain within the approved capex budget; Mehta said "All these assets are commissioned."
  • Nitric acid capacity to more than double — the Dahej project adds almost 300,000 tons versus current annual sales of around 240,000-250,000 tons; TAN capacity rises by about 380,000 tons (60-70% more) on current sales of 550,000-560,000 tons per year.
  • 75% utilization targeted in Q4 FY 2026-2027 — Tarun Sinha said ramp-up is measured from the start of commercial production, so only part of Q4 will run at that level; the CFO sees 85% immediately after and above 95% in the following year (FY 2027-2028/FY 2028-2029 framing).
  • Gopalpur commissioning slightly delayed — earlier expected by Q3 FY 2026-2027; trial runs across WNA, CNA and TAN at Dahej and Gopalpur were still underway in phases at the time of the call (Q3 FY 2026-2027).
  • Gopalpur serves a concentrated demand pocket — Tarun Sinha said the eastern states plus Singrauli in Madhya Pradesh account for 55% of India's total explosives and ammonium nitrate demand (rest of India at 45%), with mining growth there expected to be higher than in the rest of India.
  • Gopalpur customers are existing customers — already served from the Taloja plant, per the CFO; the plant was planned for eastern India and adjoining central regions such as Madhya Pradesh and Chhattisgarh, where no domestic ammonium nitrate plant exists and supply has depended on imports.
  • Funding and cost impact — about 60% of project cost is expected to be funded through term loans (period unspecified); plants are capitalized over 25 years with depreciation of roughly Rs.180-200 crore once live (period unspecified).

Export Ban Removed; Demand Shift Toward Private Mining

  • Government of India removed the export ban in October 2026 — market development for international markets started in November 2026 (Q3 FY 2026-2027) as the company works to regain lost international business.
  • Demand tilt shifting from public to private — Tarun Sinha said the public sector currently has a tilt in demand but this is changing rapidly, with "a distinct shift toward privatization over the next 5 to 10 years" as private mine developers and operators (MDOs) receive new mining leases.
  • India's ammonium nitrate market growing at a reasonable CAGR — Tarun Sinha cited coal and other mineral and rock production, and the goal to make India a Viksit Bharat by 2047, as demand drivers; he also said new domestic capacity supports Atmanirbhar Bharat and the country's energy security needs.
  • New entrant turbulence expected to be absorbed — Tarun Sinha said a new entrant typically causes initial market turbulence, which he expects the market to absorb in a "not very distant future."
  • Odisha (Gopalpur) plant on track — first commercial production targeted for Q4 FY 2026-2027; the CFO expects the plant to contribute to the bottom line from Q4 FY 2026-2027.
  • H2 FY 2026-2027 demand expected to firm — supported by customers and mining companies catching up on minerals not produced in H1 FY 2026-2027; the CFO noted H2 prices are normally firmer than the monsoon period and the company is seeing a similar trend.

Structural Cost Savings; Capex Pause; Demerger Undecided

  • Cost savings are structural, not short-term — the CFO said savings from the ammonia side and the Equinor gas contract will persist quarter on quarter, but declined to quantify, saying the numbers are not significant enough to make a material difference.
  • Margin trajectory — analyst Akshay Jawahar (Banyan Tree Associates LLP) cited operating margins of about 26% in Q1 FY 2026-2027 and 22% in Q2 FY 2026-2027; the CFO declined broad forward guidance but said margins are improved versus the previous period and expects the trajectory to continue, with some plus or minus variation, for some time.
  • 22% sustainability into FY 2027-2028 — the CFO said "not exactly 22" but within a good range, which he said should be sustainable.
  • Capex pause beyond CCPL — no major growth capex projects are currently visible apart from the already-announced CCPL project, expected to be completed in the next few quarters (period unspecified); planned capex is limited to normal maintenance for at least FY 2027-2028, with the next growth phase to be announced when decided.
  • Demerger/IPO: no timeline — asked by Parth Kotak (Plus 91 Asset Management), the CFO said discussions are ongoing internally at management level, with no timeline or decision announced yet.
  • DMSL holding dilution of about 3-3.5% — DMSL is currently a 100% subsidiary, and CCD subscriptions amount to roughly 3-3.5% of total value, so the holding would fall by that amount after conversion.
  • Employee costs rising over 40% — noted by Ritesh Bhagwati (Alpha Plus Capital) along with rising unallocated corporate costs (period unspecified); the CFO said direct costs of the new plants are capitalized, while indirect corporate office costs for project resources flow through the overall cost base.

Inflection Point Ahead, With Segment-Specific Headwinds

  • Q4 FY 2026-2027 earnings contribution from new plants — the CFO cited Gopalpur and Dahej as a near-term upside trigger, but noted contribution will be for only part of the quarter, not the full quarter; revenue will follow capacity utilization given known volumes and broadly stable pricing.
  • Structural growth driver from Q4 FY27 onward — the CFO described the new-project volumes as structural, citing existing demand for the product, and would not rule out volume contribution in H2 FY27, which he described as something "to see."
  • Mining chemicals H2 FY 2026-2027 expected stronger — per Mehta, after the monsoon slowdown; no new medium-term segment-level revenue or EBITDA figures were given on the call, as Tarun Sinha noted guidance had already been shared earlier.
  • Industrial chemicals outlook mixed — Mehta flagged tight RGB raw material availability, IPA prices supported by supply tightness, and an early, decent recovery in nitric acid pricing.
  • Crop nutrition headwinds for H2 FY 2026-2027 — Mehta flagged El Niño, raw material inflation, and high industry inventory as near-term risks.
  • Charvan Chemicals to contribute from FY28 — the CFO said the facility (located in Nagpur per the CFO, Wardha, Maharashtra per Tarun Sinha, as spoken) is being revamped to company standards and will start contributing in H2 FY28, not H1, reported incrementally under the mining solutions segment.
  • Government subsidy support — Mehta said the government's subsidy announcement made the previous week "reconfirms" support for reasonable farmer prices and industry returns; he also referenced the recent Chardham Chemicals acquisition as a step in building downstream capability.

Ask about this

Ask Cofacto a question about this call. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.